Search

Financial results - SPRINT PHARMA INTERNATIONAL S.R.L.

0.00
Financial Summary - Sprint Pharma International S.r.l.
Unique identification code: 38947622
Registration number: J2018002893401
Nace: 4646
Sales - Ron
2.878.123
Net Profit - Ron
161.516
Employees
9
Open Account
Company Sprint Pharma International S.r.l. with Fiscal Code 38947622 recorded a turnover of 2024 of 2.878.123, with a net profit of 161.516 and having an average number of employees of 9. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Sprint Pharma International S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 34.239 230.937 368.841 390.877 506.892 1.091.235 2.878.123
Total Income - EUR - - - 34.239 230.937 375.462 397.224 513.867 1.098.199 2.884.266
Total Expenses - EUR - - - 15.692 120.573 248.464 251.175 334.238 897.245 2.695.700
Gross Profit/Loss - EUR - - - 18.547 110.364 126.999 146.050 179.628 200.954 188.565
Net Profit/Loss - EUR - - - 18.543 108.951 122.247 142.078 174.492 184.394 161.516
Employees - - - 2 2 3 4 4 8 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 165.2%, from 1.091.235 euro in the year 2023, to 2.878.123 euro in 2024. The Net Profit decreased by -21.847 euro, from 184.394 euro in 2023, to 161.516 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Sprint Pharma International S.r.l.

Rating financiar

Financial Rating -
SPRINT PHARMA INTERNATIONAL S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Sprint Pharma International S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sprint Pharma International S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Sprint Pharma International S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sprint Pharma International S.r.l. - CUI 38947622

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 131 66.270 305.601 471.819 676.220 1.424.151 2.883.422
Current Assets - - - 30.190 245.868 205.488 238.381 301.134 719.721 792.855
Inventories - - - 9.791 44.125 65.504 97.744 130.893 292.699 98.740
Receivables - - - 17.537 185.487 128.022 137.404 119.597 411.048 651.126
Cash - - - 2.861 16.256 11.962 3.233 50.644 15.975 42.990
Shareholders Funds - - - 18.586 127.177 247.014 383.614 457.907 640.912 759.718
Social Capital - - - 43 42 41 40 41 40 100.557
Debts - - - 11.735 184.961 264.075 317.760 500.251 1.483.823 2.897.529
Income in Advance - - - 0 0 0 8.907 19.277 19.218 19.111
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 792.855 euro in 2024 which includes Inventories of 98.740 euro, Receivables of 651.126 euro and cash availability of 42.990 euro.
The company's Equity was valued at 759.718 euro, while total Liabilities amounted to 2.897.529 euro. Equity increased by 122.388 euro, from 640.912 euro in 2023, to 759.718 in 2024. The Debt Ratio was 78.8% in the year 2024.
Monitors the Company

Risk Reports Prices

Reviews - Sprint Pharma International S.r.l.

Comments - Sprint Pharma International S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.